Global Meningitis Vaccine Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Meningitis Vaccine market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the “Meningitis Vaccine Industry Forecast” looks at past sales and reviews total world Meningitis Vaccine sales in 2024, providing a comprehensive analysis by region and market sector of projected Meningitis Vaccine sales for 2025 through 2031. With Meningitis Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Meningitis Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Meningitis Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Meningitis Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Meningitis Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Meningitis Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Meningitis Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Meningitis Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Meningitis Vaccine market?
What factors are driving Meningitis Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Meningitis Vaccine market opportunities vary by end market size?
How does Meningitis Vaccine break out by Type, by Application?
The global Meningitis Vaccine market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the “Meningitis Vaccine Industry Forecast” looks at past sales and reviews total world Meningitis Vaccine sales in 2024, providing a comprehensive analysis by region and market sector of projected Meningitis Vaccine sales for 2025 through 2031. With Meningitis Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Meningitis Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Meningitis Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Meningitis Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Meningitis Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Meningitis Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Meningitis Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Meningitis Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Meningitis A+C
- Meningitis ACWY135
- Meningitis B
- Medical Care
- Hospital
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- GlaxoSmithKline
- Baxter International
- Sanofi Pasteur
- Merck
- Novartis
- Pfizer
- Hualan
- Zhejiang Tianyuan
- Beijing Tiantan Biological
What is the 10-year outlook for the global Meningitis Vaccine market?
What factors are driving Meningitis Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Meningitis Vaccine market opportunities vary by end market size?
How does Meningitis Vaccine break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Meningitis Vaccine Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Meningitis Vaccine by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Meningitis Vaccine by Country/Region, 2020, 2024 & 2031
2.2 Meningitis Vaccine Segment by Type
2.2.1 Meningitis A+C
2.2.2 Meningitis ACWY135
2.2.3 Meningitis B
2.3 Meningitis Vaccine Sales by Type
2.3.1 Global Meningitis Vaccine Sales Market Share by Type (2020-2025)
2.3.2 Global Meningitis Vaccine Revenue and Market Share by Type (2020-2025)
2.3.3 Global Meningitis Vaccine Sale Price by Type (2020-2025)
2.4 Meningitis Vaccine Segment by Application
2.4.1 Medical Care
2.4.2 Hospital
2.5 Meningitis Vaccine Sales by Application
2.5.1 Global Meningitis Vaccine Sale Market Share by Application (2020-2025)
2.5.2 Global Meningitis Vaccine Revenue and Market Share by Application (2020-2025)
2.5.3 Global Meningitis Vaccine Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Meningitis Vaccine Breakdown Data by Company
3.1.1 Global Meningitis Vaccine Annual Sales by Company (2020-2025)
3.1.2 Global Meningitis Vaccine Sales Market Share by Company (2020-2025)
3.2 Global Meningitis Vaccine Annual Revenue by Company (2020-2025)
3.2.1 Global Meningitis Vaccine Revenue by Company (2020-2025)
3.2.2 Global Meningitis Vaccine Revenue Market Share by Company (2020-2025)
3.3 Global Meningitis Vaccine Sale Price by Company
3.4 Key Manufacturers Meningitis Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Meningitis Vaccine Product Location Distribution
3.4.2 Players Meningitis Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR MENINGITIS VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Meningitis Vaccine Market Size by Geographic Region (2020-2025)
4.1.1 Global Meningitis Vaccine Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Meningitis Vaccine Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Meningitis Vaccine Market Size by Country/Region (2020-2025)
4.2.1 Global Meningitis Vaccine Annual Sales by Country/Region (2020-2025)
4.2.2 Global Meningitis Vaccine Annual Revenue by Country/Region (2020-2025)
4.3 Americas Meningitis Vaccine Sales Growth
4.4 APAC Meningitis Vaccine Sales Growth
4.5 Europe Meningitis Vaccine Sales Growth
4.6 Middle East & Africa Meningitis Vaccine Sales Growth
5 AMERICAS
5.1 Americas Meningitis Vaccine Sales by Country
5.1.1 Americas Meningitis Vaccine Sales by Country (2020-2025)
5.1.2 Americas Meningitis Vaccine Revenue by Country (2020-2025)
5.2 Americas Meningitis Vaccine Sales by Type (2020-2025)
5.3 Americas Meningitis Vaccine Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Meningitis Vaccine Sales by Region
6.1.1 APAC Meningitis Vaccine Sales by Region (2020-2025)
6.1.2 APAC Meningitis Vaccine Revenue by Region (2020-2025)
6.2 APAC Meningitis Vaccine Sales by Type (2020-2025)
6.3 APAC Meningitis Vaccine Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Meningitis Vaccine by Country
7.1.1 Europe Meningitis Vaccine Sales by Country (2020-2025)
7.1.2 Europe Meningitis Vaccine Revenue by Country (2020-2025)
7.2 Europe Meningitis Vaccine Sales by Type (2020-2025)
7.3 Europe Meningitis Vaccine Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Meningitis Vaccine by Country
8.1.1 Middle East & Africa Meningitis Vaccine Sales by Country (2020-2025)
8.1.2 Middle East & Africa Meningitis Vaccine Revenue by Country (2020-2025)
8.2 Middle East & Africa Meningitis Vaccine Sales by Type (2020-2025)
8.3 Middle East & Africa Meningitis Vaccine Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Meningitis Vaccine
10.3 Manufacturing Process Analysis of Meningitis Vaccine
10.4 Industry Chain Structure of Meningitis Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Meningitis Vaccine Distributors
11.3 Meningitis Vaccine Customer
12 WORLD FORECAST REVIEW FOR MENINGITIS VACCINE BY GEOGRAPHIC REGION
12.1 Global Meningitis Vaccine Market Size Forecast by Region
12.1.1 Global Meningitis Vaccine Forecast by Region (2026-2031)
12.1.2 Global Meningitis Vaccine Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Meningitis Vaccine Forecast by Type (2026-2031)
12.7 Global Meningitis Vaccine Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 GlaxoSmithKline
13.1.1 GlaxoSmithKline Company Information
13.1.2 GlaxoSmithKline Meningitis Vaccine Product Portfolios and Specifications
13.1.3 GlaxoSmithKline Meningitis Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 GlaxoSmithKline Main Business Overview
13.1.5 GlaxoSmithKline Latest Developments
13.2 Baxter International
13.2.1 Baxter International Company Information
13.2.2 Baxter International Meningitis Vaccine Product Portfolios and Specifications
13.2.3 Baxter International Meningitis Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Baxter International Main Business Overview
13.2.5 Baxter International Latest Developments
13.3 Sanofi Pasteur
13.3.1 Sanofi Pasteur Company Information
13.3.2 Sanofi Pasteur Meningitis Vaccine Product Portfolios and Specifications
13.3.3 Sanofi Pasteur Meningitis Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Sanofi Pasteur Main Business Overview
13.3.5 Sanofi Pasteur Latest Developments
13.4 Merck
13.4.1 Merck Company Information
13.4.2 Merck Meningitis Vaccine Product Portfolios and Specifications
13.4.3 Merck Meningitis Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Merck Main Business Overview
13.4.5 Merck Latest Developments
13.5 Novartis
13.5.1 Novartis Company Information
13.5.2 Novartis Meningitis Vaccine Product Portfolios and Specifications
13.5.3 Novartis Meningitis Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Novartis Main Business Overview
13.5.5 Novartis Latest Developments
13.6 Pfizer
13.6.1 Pfizer Company Information
13.6.2 Pfizer Meningitis Vaccine Product Portfolios and Specifications
13.6.3 Pfizer Meningitis Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Pfizer Main Business Overview
13.6.5 Pfizer Latest Developments
13.7 Hualan
13.7.1 Hualan Company Information
13.7.2 Hualan Meningitis Vaccine Product Portfolios and Specifications
13.7.3 Hualan Meningitis Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Hualan Main Business Overview
13.7.5 Hualan Latest Developments
13.8 Zhejiang Tianyuan
13.8.1 Zhejiang Tianyuan Company Information
13.8.2 Zhejiang Tianyuan Meningitis Vaccine Product Portfolios and Specifications
13.8.3 Zhejiang Tianyuan Meningitis Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Zhejiang Tianyuan Main Business Overview
13.8.5 Zhejiang Tianyuan Latest Developments
13.9 Beijing Tiantan Biological
13.9.1 Beijing Tiantan Biological Company Information
13.9.2 Beijing Tiantan Biological Meningitis Vaccine Product Portfolios and Specifications
13.9.3 Beijing Tiantan Biological Meningitis Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Beijing Tiantan Biological Main Business Overview
13.9.5 Beijing Tiantan Biological Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Meningitis Vaccine Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Meningitis Vaccine Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Meningitis A+C
Table 4. Major Players of Meningitis ACWY135
Table 5. Major Players of Meningitis B
Table 6. Global Meningitis Vaccine Sales byType (2020-2025) & (K MT)
Table 7. Global Meningitis Vaccine Sales Market Share byType (2020-2025)
Table 8. Global Meningitis Vaccine Revenue byType (2020-2025) & ($ million)
Table 9. Global Meningitis Vaccine Revenue Market Share byType (2020-2025)
Table 10. Global Meningitis Vaccine Sale Price byType (2020-2025) & (USD/MT)
Table 11. Global Meningitis Vaccine Sale by Application (2020-2025) & (K MT)
Table 12. Global Meningitis Vaccine Sale Market Share by Application (2020-2025)
Table 13. Global Meningitis Vaccine Revenue by Application (2020-2025) & ($ million)
Table 14. Global Meningitis Vaccine Revenue Market Share by Application (2020-2025)
Table 15. Global Meningitis Vaccine Sale Price by Application (2020-2025) & (USD/MT)
Table 16. Global Meningitis Vaccine Sales by Company (2020-2025) & (K MT)
Table 17. Global Meningitis Vaccine Sales Market Share by Company (2020-2025)
Table 18. Global Meningitis Vaccine Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Meningitis Vaccine Revenue Market Share by Company (2020-2025)
Table 20. Global Meningitis Vaccine Sale Price by Company (2020-2025) & (USD/MT)
Table 21. Key Manufacturers Meningitis Vaccine Producing Area Distribution and Sales Area
Table 22. Players Meningitis Vaccine Products Offered
Table 23. Meningitis Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Meningitis Vaccine Sales by Geographic Region (2020-2025) & (K MT)
Table 27. Global Meningitis Vaccine Sales Market Share Geographic Region (2020-2025)
Table 28. Global Meningitis Vaccine Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Meningitis Vaccine Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Meningitis Vaccine Sales by Country/Region (2020-2025) & (K MT)
Table 31. Global Meningitis Vaccine Sales Market Share by Country/Region (2020-2025)
Table 32. Global Meningitis Vaccine Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Meningitis Vaccine Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Meningitis Vaccine Sales by Country (2020-2025) & (K MT)
Table 35. Americas Meningitis Vaccine Sales Market Share by Country (2020-2025)
Table 36. Americas Meningitis Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Meningitis Vaccine Sales byType (2020-2025) & (K MT)
Table 38. Americas Meningitis Vaccine Sales by Application (2020-2025) & (K MT)
Table 39. APAC Meningitis Vaccine Sales by Region (2020-2025) & (K MT)
Table 40. APAC Meningitis Vaccine Sales Market Share by Region (2020-2025)
Table 41. APAC Meningitis Vaccine Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Meningitis Vaccine Sales byType (2020-2025) & (K MT)
Table 43. APAC Meningitis Vaccine Sales by Application (2020-2025) & (K MT)
Table 44. Europe Meningitis Vaccine Sales by Country (2020-2025) & (K MT)
Table 45. Europe Meningitis Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Meningitis Vaccine Sales byType (2020-2025) & (K MT)
Table 47. Europe Meningitis Vaccine Sales by Application (2020-2025) & (K MT)
Table 48. Middle East & Africa Meningitis Vaccine Sales by Country (2020-2025) & (K MT)
Table 49. Middle East & Africa Meningitis Vaccine Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Meningitis Vaccine Sales byType (2020-2025) & (K MT)
Table 51. Middle East & Africa Meningitis Vaccine Sales by Application (2020-2025) & (K MT)
Table 52. Key Market Drivers & Growth Opportunities of Meningitis Vaccine
Table 53. Key Market Challenges & Risks of Meningitis Vaccine
Table 54. Key IndustryTrends of Meningitis Vaccine
Table 55. Meningitis Vaccine Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Meningitis Vaccine Distributors List
Table 58. Meningitis Vaccine Customer List
Table 59. Global Meningitis Vaccine SalesForecast by Region (2026-2031) & (K MT)
Table 60. Global Meningitis Vaccine RevenueForecast by Region (2026-2031) & ($ millions)
Table 61. Americas Meningitis Vaccine SalesForecast by Country (2026-2031) & (K MT)
Table 62. Americas Meningitis Vaccine Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 63. APAC Meningitis Vaccine SalesForecast by Region (2026-2031) & (K MT)
Table 64. APAC Meningitis Vaccine Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 65. Europe Meningitis Vaccine SalesForecast by Country (2026-2031) & (K MT)
Table 66. Europe Meningitis Vaccine RevenueForecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Meningitis Vaccine SalesForecast by Country (2026-2031) & (K MT)
Table 68. Middle East & Africa Meningitis Vaccine RevenueForecast by Country (2026-2031) & ($ millions)
Table 69. Global Meningitis Vaccine SalesForecast byType (2026-2031) & (K MT)
Table 70. Global Meningitis Vaccine RevenueForecast byType (2026-2031) & ($ millions)
Table 71. Global Meningitis Vaccine SalesForecast by Application (2026-2031) & (K MT)
Table 72. Global Meningitis Vaccine RevenueForecast by Application (2026-2031) & ($ millions)
Table 73. GlaxoSmithKline Basic Information, Meningitis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 74. GlaxoSmithKline Meningitis Vaccine Product Portfolios and Specifications
Table 75. GlaxoSmithKline Meningitis Vaccine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 76. GlaxoSmithKline Main Business
Table 77. GlaxoSmithKline Latest Developments
Table 78. Baxter International Basic Information, Meningitis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. Baxter International Meningitis Vaccine Product Portfolios and Specifications
Table 80. Baxter International Meningitis Vaccine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 81. Baxter International Main Business
Table 82. Baxter International Latest Developments
Table 83. Sanofi Pasteur Basic Information, Meningitis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. Sanofi Pasteur Meningitis Vaccine Product Portfolios and Specifications
Table 85. Sanofi Pasteur Meningitis Vaccine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 86. Sanofi Pasteur Main Business
Table 87. Sanofi Pasteur Latest Developments
Table 88. Merck Basic Information, Meningitis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. Merck Meningitis Vaccine Product Portfolios and Specifications
Table 90. Merck Meningitis Vaccine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 91. Merck Main Business
Table 92. Merck Latest Developments
Table 93. Novartis Basic Information, Meningitis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. Novartis Meningitis Vaccine Product Portfolios and Specifications
Table 95. Novartis Meningitis Vaccine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 96. Novartis Main Business
Table 97. Novartis Latest Developments
Table 98. Pfizer Basic Information, Meningitis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 99. Pfizer Meningitis Vaccine Product Portfolios and Specifications
Table 100. Pfizer Meningitis Vaccine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 101. Pfizer Main Business
Table 102. Pfizer Latest Developments
Table 103. Hualan Basic Information, Meningitis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 104. Hualan Meningitis Vaccine Product Portfolios and Specifications
Table 105. Hualan Meningitis Vaccine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 106. Hualan Main Business
Table 107. Hualan Latest Developments
Table 108. ZhejiangTianyuan Basic Information, Meningitis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 109. ZhejiangTianyuan Meningitis Vaccine Product Portfolios and Specifications
Table 110. ZhejiangTianyuan Meningitis Vaccine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 111. ZhejiangTianyuan Main Business
Table 112. ZhejiangTianyuan Latest Developments
Table 113. BeijingTiantan Biological Basic Information, Meningitis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 114. BeijingTiantan Biological Meningitis Vaccine Product Portfolios and Specifications
Table 115. BeijingTiantan Biological Meningitis Vaccine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 116. BeijingTiantan Biological Main Business
Table 117. BeijingTiantan Biological Latest Developments
LIST OFFIGURES
Figure 1. Picture of Meningitis Vaccine
Figure 2. Meningitis Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Meningitis Vaccine Sales Growth Rate 2020-2031 (K MT)
Figure 7. Global Meningitis Vaccine Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Meningitis Vaccine Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Meningitis Vaccine Sales Market Share by Country/Region (2024)
Figure 10. Meningitis Vaccine Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Meningitis A+C
Figure 12. Product Picture of Meningitis ACWY135
Figure 13. Product Picture of Meningitis B
Figure 14. Global Meningitis Vaccine Sales Market Share byType in 2025
Figure 15. Global Meningitis Vaccine Revenue Market Share byType (2020-2025)
Figure 16. Meningitis Vaccine Consumed in Medical Care
Figure 17. Global Meningitis Vaccine Market: Medical Care (2020-2025) & (K MT)
Figure 18. Meningitis Vaccine Consumed in Hospital
Figure 19. Global Meningitis Vaccine Market: Hospital (2020-2025) & (K MT)
Figure 20. Global Meningitis Vaccine Sale Market Share by Application (2024)
Figure 21. Global Meningitis Vaccine Revenue Market Share by Application in 2025
Figure 22. Meningitis Vaccine Sales by Company in 2025 (K MT)
Figure 23. Global Meningitis Vaccine Sales Market Share by Company in 2025
Figure 24. Meningitis Vaccine Revenue by Company in 2025 ($ millions)
Figure 25. Global Meningitis Vaccine Revenue Market Share by Company in 2025
Figure 26. Global Meningitis Vaccine Sales Market Share by Geographic Region (2020-2025)
Figure 27. Global Meningitis Vaccine Revenue Market Share by Geographic Region in 2025
Figure 28. Americas Meningitis Vaccine Sales 2020-2025 (K MT)
Figure 29. Americas Meningitis Vaccine Revenue 2020-2025 ($ millions)
Figure 30. APAC Meningitis Vaccine Sales 2020-2025 (K MT)
Figure 31. APAC Meningitis Vaccine Revenue 2020-2025 ($ millions)
Figure 32. Europe Meningitis Vaccine Sales 2020-2025 (K MT)
Figure 33. Europe Meningitis Vaccine Revenue 2020-2025 ($ millions)
Figure 34. Middle East & Africa Meningitis Vaccine Sales 2020-2025 (K MT)
Figure 35. Middle East & Africa Meningitis Vaccine Revenue 2020-2025 ($ millions)
Figure 36. Americas Meningitis Vaccine Sales Market Share by Country in 2025
Figure 37. Americas Meningitis Vaccine Revenue Market Share by Country (2020-2025)
Figure 38. Americas Meningitis Vaccine Sales Market Share byType (2020-2025)
Figure 39. Americas Meningitis Vaccine Sales Market Share by Application (2020-2025)
Figure 40. United States Meningitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 41. Canada Meningitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 42. Mexico Meningitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 43. Brazil Meningitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 44. APAC Meningitis Vaccine Sales Market Share by Region in 2025
Figure 45. APAC Meningitis Vaccine Revenue Market Share by Region (2020-2025)
Figure 46. APAC Meningitis Vaccine Sales Market Share byType (2020-2025)
Figure 47. APAC Meningitis Vaccine Sales Market Share by Application (2020-2025)
Figure 48. China Meningitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 49. Japan Meningitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 50. South Korea Meningitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 51. Southeast Asia Meningitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 52. India Meningitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 53. Australia Meningitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 54. ChinaTaiwan Meningitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 55. Europe Meningitis Vaccine Sales Market Share by Country in 2025
Figure 56. Europe Meningitis Vaccine Revenue Market Share by Country (2020-2025)
Figure 57. Europe Meningitis Vaccine Sales Market Share byType (2020-2025)
Figure 58. Europe Meningitis Vaccine Sales Market Share by Application (2020-2025)
Figure 59. Germany Meningitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 60.France Meningitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 61. UK Meningitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 62. Italy Meningitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 63. Russia Meningitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 64. Middle East & Africa Meningitis Vaccine Sales Market Share by Country (2020-2025)
Figure 65. Middle East & Africa Meningitis Vaccine Sales Market Share byType (2020-2025)
Figure 66. Middle East & Africa Meningitis Vaccine Sales Market Share by Application (2020-2025)
Figure 67. Egypt Meningitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 68. South Africa Meningitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 69. Israel Meningitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 70.Turkey Meningitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 71. GCC Countries Meningitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 72. Manufacturing Cost Structure Analysis of Meningitis Vaccine in 2025
Figure 73. Manufacturing Process Analysis of Meningitis Vaccine
Figure 74. Industry Chain Structure of Meningitis Vaccine
Figure 75. Channels of Distribution
Figure 76. Global Meningitis Vaccine Sales MarketForecast by Region (2026-2031)
Figure 77. Global Meningitis Vaccine Revenue Market ShareForecast by Region (2026-2031)
Figure 78. Global Meningitis Vaccine Sales Market ShareForecast byType (2026-2031)
Figure 79. Global Meningitis Vaccine Revenue Market ShareForecast byType (2026-2031)
Figure 80. Global Meningitis Vaccine Sales Market ShareForecast by Application (2026-2031)
Figure 81. Global Meningitis Vaccine Revenue Market ShareForecast by Application (2026-2031)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Meningitis Vaccine Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Meningitis Vaccine by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Meningitis Vaccine by Country/Region, 2020, 2024 & 2031
2.2 Meningitis Vaccine Segment by Type
2.2.1 Meningitis A+C
2.2.2 Meningitis ACWY135
2.2.3 Meningitis B
2.3 Meningitis Vaccine Sales by Type
2.3.1 Global Meningitis Vaccine Sales Market Share by Type (2020-2025)
2.3.2 Global Meningitis Vaccine Revenue and Market Share by Type (2020-2025)
2.3.3 Global Meningitis Vaccine Sale Price by Type (2020-2025)
2.4 Meningitis Vaccine Segment by Application
2.4.1 Medical Care
2.4.2 Hospital
2.5 Meningitis Vaccine Sales by Application
2.5.1 Global Meningitis Vaccine Sale Market Share by Application (2020-2025)
2.5.2 Global Meningitis Vaccine Revenue and Market Share by Application (2020-2025)
2.5.3 Global Meningitis Vaccine Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Meningitis Vaccine Breakdown Data by Company
3.1.1 Global Meningitis Vaccine Annual Sales by Company (2020-2025)
3.1.2 Global Meningitis Vaccine Sales Market Share by Company (2020-2025)
3.2 Global Meningitis Vaccine Annual Revenue by Company (2020-2025)
3.2.1 Global Meningitis Vaccine Revenue by Company (2020-2025)
3.2.2 Global Meningitis Vaccine Revenue Market Share by Company (2020-2025)
3.3 Global Meningitis Vaccine Sale Price by Company
3.4 Key Manufacturers Meningitis Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Meningitis Vaccine Product Location Distribution
3.4.2 Players Meningitis Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR MENINGITIS VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Meningitis Vaccine Market Size by Geographic Region (2020-2025)
4.1.1 Global Meningitis Vaccine Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Meningitis Vaccine Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Meningitis Vaccine Market Size by Country/Region (2020-2025)
4.2.1 Global Meningitis Vaccine Annual Sales by Country/Region (2020-2025)
4.2.2 Global Meningitis Vaccine Annual Revenue by Country/Region (2020-2025)
4.3 Americas Meningitis Vaccine Sales Growth
4.4 APAC Meningitis Vaccine Sales Growth
4.5 Europe Meningitis Vaccine Sales Growth
4.6 Middle East & Africa Meningitis Vaccine Sales Growth
5 AMERICAS
5.1 Americas Meningitis Vaccine Sales by Country
5.1.1 Americas Meningitis Vaccine Sales by Country (2020-2025)
5.1.2 Americas Meningitis Vaccine Revenue by Country (2020-2025)
5.2 Americas Meningitis Vaccine Sales by Type (2020-2025)
5.3 Americas Meningitis Vaccine Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Meningitis Vaccine Sales by Region
6.1.1 APAC Meningitis Vaccine Sales by Region (2020-2025)
6.1.2 APAC Meningitis Vaccine Revenue by Region (2020-2025)
6.2 APAC Meningitis Vaccine Sales by Type (2020-2025)
6.3 APAC Meningitis Vaccine Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Meningitis Vaccine by Country
7.1.1 Europe Meningitis Vaccine Sales by Country (2020-2025)
7.1.2 Europe Meningitis Vaccine Revenue by Country (2020-2025)
7.2 Europe Meningitis Vaccine Sales by Type (2020-2025)
7.3 Europe Meningitis Vaccine Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Meningitis Vaccine by Country
8.1.1 Middle East & Africa Meningitis Vaccine Sales by Country (2020-2025)
8.1.2 Middle East & Africa Meningitis Vaccine Revenue by Country (2020-2025)
8.2 Middle East & Africa Meningitis Vaccine Sales by Type (2020-2025)
8.3 Middle East & Africa Meningitis Vaccine Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Meningitis Vaccine
10.3 Manufacturing Process Analysis of Meningitis Vaccine
10.4 Industry Chain Structure of Meningitis Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Meningitis Vaccine Distributors
11.3 Meningitis Vaccine Customer
12 WORLD FORECAST REVIEW FOR MENINGITIS VACCINE BY GEOGRAPHIC REGION
12.1 Global Meningitis Vaccine Market Size Forecast by Region
12.1.1 Global Meningitis Vaccine Forecast by Region (2026-2031)
12.1.2 Global Meningitis Vaccine Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Meningitis Vaccine Forecast by Type (2026-2031)
12.7 Global Meningitis Vaccine Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 GlaxoSmithKline
13.1.1 GlaxoSmithKline Company Information
13.1.2 GlaxoSmithKline Meningitis Vaccine Product Portfolios and Specifications
13.1.3 GlaxoSmithKline Meningitis Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 GlaxoSmithKline Main Business Overview
13.1.5 GlaxoSmithKline Latest Developments
13.2 Baxter International
13.2.1 Baxter International Company Information
13.2.2 Baxter International Meningitis Vaccine Product Portfolios and Specifications
13.2.3 Baxter International Meningitis Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Baxter International Main Business Overview
13.2.5 Baxter International Latest Developments
13.3 Sanofi Pasteur
13.3.1 Sanofi Pasteur Company Information
13.3.2 Sanofi Pasteur Meningitis Vaccine Product Portfolios and Specifications
13.3.3 Sanofi Pasteur Meningitis Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Sanofi Pasteur Main Business Overview
13.3.5 Sanofi Pasteur Latest Developments
13.4 Merck
13.4.1 Merck Company Information
13.4.2 Merck Meningitis Vaccine Product Portfolios and Specifications
13.4.3 Merck Meningitis Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Merck Main Business Overview
13.4.5 Merck Latest Developments
13.5 Novartis
13.5.1 Novartis Company Information
13.5.2 Novartis Meningitis Vaccine Product Portfolios and Specifications
13.5.3 Novartis Meningitis Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Novartis Main Business Overview
13.5.5 Novartis Latest Developments
13.6 Pfizer
13.6.1 Pfizer Company Information
13.6.2 Pfizer Meningitis Vaccine Product Portfolios and Specifications
13.6.3 Pfizer Meningitis Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Pfizer Main Business Overview
13.6.5 Pfizer Latest Developments
13.7 Hualan
13.7.1 Hualan Company Information
13.7.2 Hualan Meningitis Vaccine Product Portfolios and Specifications
13.7.3 Hualan Meningitis Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Hualan Main Business Overview
13.7.5 Hualan Latest Developments
13.8 Zhejiang Tianyuan
13.8.1 Zhejiang Tianyuan Company Information
13.8.2 Zhejiang Tianyuan Meningitis Vaccine Product Portfolios and Specifications
13.8.3 Zhejiang Tianyuan Meningitis Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Zhejiang Tianyuan Main Business Overview
13.8.5 Zhejiang Tianyuan Latest Developments
13.9 Beijing Tiantan Biological
13.9.1 Beijing Tiantan Biological Company Information
13.9.2 Beijing Tiantan Biological Meningitis Vaccine Product Portfolios and Specifications
13.9.3 Beijing Tiantan Biological Meningitis Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Beijing Tiantan Biological Main Business Overview
13.9.5 Beijing Tiantan Biological Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Meningitis Vaccine Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Meningitis Vaccine Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Meningitis A+C
Table 4. Major Players of Meningitis ACWY135
Table 5. Major Players of Meningitis B
Table 6. Global Meningitis Vaccine Sales byType (2020-2025) & (K MT)
Table 7. Global Meningitis Vaccine Sales Market Share byType (2020-2025)
Table 8. Global Meningitis Vaccine Revenue byType (2020-2025) & ($ million)
Table 9. Global Meningitis Vaccine Revenue Market Share byType (2020-2025)
Table 10. Global Meningitis Vaccine Sale Price byType (2020-2025) & (USD/MT)
Table 11. Global Meningitis Vaccine Sale by Application (2020-2025) & (K MT)
Table 12. Global Meningitis Vaccine Sale Market Share by Application (2020-2025)
Table 13. Global Meningitis Vaccine Revenue by Application (2020-2025) & ($ million)
Table 14. Global Meningitis Vaccine Revenue Market Share by Application (2020-2025)
Table 15. Global Meningitis Vaccine Sale Price by Application (2020-2025) & (USD/MT)
Table 16. Global Meningitis Vaccine Sales by Company (2020-2025) & (K MT)
Table 17. Global Meningitis Vaccine Sales Market Share by Company (2020-2025)
Table 18. Global Meningitis Vaccine Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Meningitis Vaccine Revenue Market Share by Company (2020-2025)
Table 20. Global Meningitis Vaccine Sale Price by Company (2020-2025) & (USD/MT)
Table 21. Key Manufacturers Meningitis Vaccine Producing Area Distribution and Sales Area
Table 22. Players Meningitis Vaccine Products Offered
Table 23. Meningitis Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Meningitis Vaccine Sales by Geographic Region (2020-2025) & (K MT)
Table 27. Global Meningitis Vaccine Sales Market Share Geographic Region (2020-2025)
Table 28. Global Meningitis Vaccine Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Meningitis Vaccine Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Meningitis Vaccine Sales by Country/Region (2020-2025) & (K MT)
Table 31. Global Meningitis Vaccine Sales Market Share by Country/Region (2020-2025)
Table 32. Global Meningitis Vaccine Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Meningitis Vaccine Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Meningitis Vaccine Sales by Country (2020-2025) & (K MT)
Table 35. Americas Meningitis Vaccine Sales Market Share by Country (2020-2025)
Table 36. Americas Meningitis Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Meningitis Vaccine Sales byType (2020-2025) & (K MT)
Table 38. Americas Meningitis Vaccine Sales by Application (2020-2025) & (K MT)
Table 39. APAC Meningitis Vaccine Sales by Region (2020-2025) & (K MT)
Table 40. APAC Meningitis Vaccine Sales Market Share by Region (2020-2025)
Table 41. APAC Meningitis Vaccine Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Meningitis Vaccine Sales byType (2020-2025) & (K MT)
Table 43. APAC Meningitis Vaccine Sales by Application (2020-2025) & (K MT)
Table 44. Europe Meningitis Vaccine Sales by Country (2020-2025) & (K MT)
Table 45. Europe Meningitis Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Meningitis Vaccine Sales byType (2020-2025) & (K MT)
Table 47. Europe Meningitis Vaccine Sales by Application (2020-2025) & (K MT)
Table 48. Middle East & Africa Meningitis Vaccine Sales by Country (2020-2025) & (K MT)
Table 49. Middle East & Africa Meningitis Vaccine Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Meningitis Vaccine Sales byType (2020-2025) & (K MT)
Table 51. Middle East & Africa Meningitis Vaccine Sales by Application (2020-2025) & (K MT)
Table 52. Key Market Drivers & Growth Opportunities of Meningitis Vaccine
Table 53. Key Market Challenges & Risks of Meningitis Vaccine
Table 54. Key IndustryTrends of Meningitis Vaccine
Table 55. Meningitis Vaccine Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Meningitis Vaccine Distributors List
Table 58. Meningitis Vaccine Customer List
Table 59. Global Meningitis Vaccine SalesForecast by Region (2026-2031) & (K MT)
Table 60. Global Meningitis Vaccine RevenueForecast by Region (2026-2031) & ($ millions)
Table 61. Americas Meningitis Vaccine SalesForecast by Country (2026-2031) & (K MT)
Table 62. Americas Meningitis Vaccine Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 63. APAC Meningitis Vaccine SalesForecast by Region (2026-2031) & (K MT)
Table 64. APAC Meningitis Vaccine Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 65. Europe Meningitis Vaccine SalesForecast by Country (2026-2031) & (K MT)
Table 66. Europe Meningitis Vaccine RevenueForecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Meningitis Vaccine SalesForecast by Country (2026-2031) & (K MT)
Table 68. Middle East & Africa Meningitis Vaccine RevenueForecast by Country (2026-2031) & ($ millions)
Table 69. Global Meningitis Vaccine SalesForecast byType (2026-2031) & (K MT)
Table 70. Global Meningitis Vaccine RevenueForecast byType (2026-2031) & ($ millions)
Table 71. Global Meningitis Vaccine SalesForecast by Application (2026-2031) & (K MT)
Table 72. Global Meningitis Vaccine RevenueForecast by Application (2026-2031) & ($ millions)
Table 73. GlaxoSmithKline Basic Information, Meningitis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 74. GlaxoSmithKline Meningitis Vaccine Product Portfolios and Specifications
Table 75. GlaxoSmithKline Meningitis Vaccine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 76. GlaxoSmithKline Main Business
Table 77. GlaxoSmithKline Latest Developments
Table 78. Baxter International Basic Information, Meningitis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. Baxter International Meningitis Vaccine Product Portfolios and Specifications
Table 80. Baxter International Meningitis Vaccine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 81. Baxter International Main Business
Table 82. Baxter International Latest Developments
Table 83. Sanofi Pasteur Basic Information, Meningitis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. Sanofi Pasteur Meningitis Vaccine Product Portfolios and Specifications
Table 85. Sanofi Pasteur Meningitis Vaccine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 86. Sanofi Pasteur Main Business
Table 87. Sanofi Pasteur Latest Developments
Table 88. Merck Basic Information, Meningitis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. Merck Meningitis Vaccine Product Portfolios and Specifications
Table 90. Merck Meningitis Vaccine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 91. Merck Main Business
Table 92. Merck Latest Developments
Table 93. Novartis Basic Information, Meningitis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. Novartis Meningitis Vaccine Product Portfolios and Specifications
Table 95. Novartis Meningitis Vaccine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 96. Novartis Main Business
Table 97. Novartis Latest Developments
Table 98. Pfizer Basic Information, Meningitis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 99. Pfizer Meningitis Vaccine Product Portfolios and Specifications
Table 100. Pfizer Meningitis Vaccine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 101. Pfizer Main Business
Table 102. Pfizer Latest Developments
Table 103. Hualan Basic Information, Meningitis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 104. Hualan Meningitis Vaccine Product Portfolios and Specifications
Table 105. Hualan Meningitis Vaccine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 106. Hualan Main Business
Table 107. Hualan Latest Developments
Table 108. ZhejiangTianyuan Basic Information, Meningitis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 109. ZhejiangTianyuan Meningitis Vaccine Product Portfolios and Specifications
Table 110. ZhejiangTianyuan Meningitis Vaccine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 111. ZhejiangTianyuan Main Business
Table 112. ZhejiangTianyuan Latest Developments
Table 113. BeijingTiantan Biological Basic Information, Meningitis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 114. BeijingTiantan Biological Meningitis Vaccine Product Portfolios and Specifications
Table 115. BeijingTiantan Biological Meningitis Vaccine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 116. BeijingTiantan Biological Main Business
Table 117. BeijingTiantan Biological Latest Developments
LIST OFFIGURES
Figure 1. Picture of Meningitis Vaccine
Figure 2. Meningitis Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Meningitis Vaccine Sales Growth Rate 2020-2031 (K MT)
Figure 7. Global Meningitis Vaccine Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Meningitis Vaccine Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Meningitis Vaccine Sales Market Share by Country/Region (2024)
Figure 10. Meningitis Vaccine Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Meningitis A+C
Figure 12. Product Picture of Meningitis ACWY135
Figure 13. Product Picture of Meningitis B
Figure 14. Global Meningitis Vaccine Sales Market Share byType in 2025
Figure 15. Global Meningitis Vaccine Revenue Market Share byType (2020-2025)
Figure 16. Meningitis Vaccine Consumed in Medical Care
Figure 17. Global Meningitis Vaccine Market: Medical Care (2020-2025) & (K MT)
Figure 18. Meningitis Vaccine Consumed in Hospital
Figure 19. Global Meningitis Vaccine Market: Hospital (2020-2025) & (K MT)
Figure 20. Global Meningitis Vaccine Sale Market Share by Application (2024)
Figure 21. Global Meningitis Vaccine Revenue Market Share by Application in 2025
Figure 22. Meningitis Vaccine Sales by Company in 2025 (K MT)
Figure 23. Global Meningitis Vaccine Sales Market Share by Company in 2025
Figure 24. Meningitis Vaccine Revenue by Company in 2025 ($ millions)
Figure 25. Global Meningitis Vaccine Revenue Market Share by Company in 2025
Figure 26. Global Meningitis Vaccine Sales Market Share by Geographic Region (2020-2025)
Figure 27. Global Meningitis Vaccine Revenue Market Share by Geographic Region in 2025
Figure 28. Americas Meningitis Vaccine Sales 2020-2025 (K MT)
Figure 29. Americas Meningitis Vaccine Revenue 2020-2025 ($ millions)
Figure 30. APAC Meningitis Vaccine Sales 2020-2025 (K MT)
Figure 31. APAC Meningitis Vaccine Revenue 2020-2025 ($ millions)
Figure 32. Europe Meningitis Vaccine Sales 2020-2025 (K MT)
Figure 33. Europe Meningitis Vaccine Revenue 2020-2025 ($ millions)
Figure 34. Middle East & Africa Meningitis Vaccine Sales 2020-2025 (K MT)
Figure 35. Middle East & Africa Meningitis Vaccine Revenue 2020-2025 ($ millions)
Figure 36. Americas Meningitis Vaccine Sales Market Share by Country in 2025
Figure 37. Americas Meningitis Vaccine Revenue Market Share by Country (2020-2025)
Figure 38. Americas Meningitis Vaccine Sales Market Share byType (2020-2025)
Figure 39. Americas Meningitis Vaccine Sales Market Share by Application (2020-2025)
Figure 40. United States Meningitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 41. Canada Meningitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 42. Mexico Meningitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 43. Brazil Meningitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 44. APAC Meningitis Vaccine Sales Market Share by Region in 2025
Figure 45. APAC Meningitis Vaccine Revenue Market Share by Region (2020-2025)
Figure 46. APAC Meningitis Vaccine Sales Market Share byType (2020-2025)
Figure 47. APAC Meningitis Vaccine Sales Market Share by Application (2020-2025)
Figure 48. China Meningitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 49. Japan Meningitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 50. South Korea Meningitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 51. Southeast Asia Meningitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 52. India Meningitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 53. Australia Meningitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 54. ChinaTaiwan Meningitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 55. Europe Meningitis Vaccine Sales Market Share by Country in 2025
Figure 56. Europe Meningitis Vaccine Revenue Market Share by Country (2020-2025)
Figure 57. Europe Meningitis Vaccine Sales Market Share byType (2020-2025)
Figure 58. Europe Meningitis Vaccine Sales Market Share by Application (2020-2025)
Figure 59. Germany Meningitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 60.France Meningitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 61. UK Meningitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 62. Italy Meningitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 63. Russia Meningitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 64. Middle East & Africa Meningitis Vaccine Sales Market Share by Country (2020-2025)
Figure 65. Middle East & Africa Meningitis Vaccine Sales Market Share byType (2020-2025)
Figure 66. Middle East & Africa Meningitis Vaccine Sales Market Share by Application (2020-2025)
Figure 67. Egypt Meningitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 68. South Africa Meningitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 69. Israel Meningitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 70.Turkey Meningitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 71. GCC Countries Meningitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 72. Manufacturing Cost Structure Analysis of Meningitis Vaccine in 2025
Figure 73. Manufacturing Process Analysis of Meningitis Vaccine
Figure 74. Industry Chain Structure of Meningitis Vaccine
Figure 75. Channels of Distribution
Figure 76. Global Meningitis Vaccine Sales MarketForecast by Region (2026-2031)
Figure 77. Global Meningitis Vaccine Revenue Market ShareForecast by Region (2026-2031)
Figure 78. Global Meningitis Vaccine Sales Market ShareForecast byType (2026-2031)
Figure 79. Global Meningitis Vaccine Revenue Market ShareForecast byType (2026-2031)
Figure 80. Global Meningitis Vaccine Sales Market ShareForecast by Application (2026-2031)
Figure 81. Global Meningitis Vaccine Revenue Market ShareForecast by Application (2026-2031)
More Publications
Global Chlamydia Trachomatis Antibodies Market Growth 2023-2029
US$ 3,660.00
March 2023
111 pages
Global Video Colposcope Market Growth 2025-2031
US$ 3,660.00
March 2025
106 pages
Global Medical Smoke Evacuators Market Growth 2024-2030
US$ 3,660.00
December 2024
110 pages
Global Electromyogram Monitoring Market Growth (Status and Outlook) 2024-2030
US$ 3,660.00
December 2024
126 pages
Global Self-Monitoring Blood Glucose (SMBG) Devices Market Growth 2025-2031
US$ 3,660.00
March 2025
81 pages
